GENE ONLINE|News &
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
Looking ahead, Vertex forecasts total revenue between $11.75 billion and $12.0 billion for the coming year, aligning closely with consensus estimates at the midpoint, according to Leerink.
Suzetrigine, a novel painkiller, has received approval from the US Food and Drug Administration (FDA) for short-term pain management, making it the first new pain …
GO Prime with only $1.49 now
LATEST
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
